Indonesia vs Myanmar: Average cost of drugs for extensively drug-resistant tuberculosis
Indonesia
1,138 constant 2022 US$
in 2024
Myanmar
963 constant 2022 US$
in 2024
Indonesia rank
40th
Myanmar rank
43rd
Average cost of drugs for extensively drug-resistant tuberculosis over time
- Indonesia
- Myanmar
How they compare
Indonesia currently reports 1,138 constant 2022 US$ against 963 constant 2022 US$ in Myanmar, a difference of 175 constant 2022 US$.
That makes Indonesia's figure about 1.2 times Myanmar's.
The two have swapped places 1 time across 5 shared years of data; in 2020 it was Myanmar ahead.
Indonesia ranks 40th and Myanmar ranks 43rd of 56 countries.
Myanmar has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Indonesia or Myanmar?
- Indonesia, at 1,138 constant 2022 US$ against 963 constant 2022 US$ in Myanmar as of 2024.
- What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Indonesia and Myanmar?
- 175 constant 2022 US$, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Myanmar?
- 5 years are reported by both, from 2020 to 2024.
- How do Indonesia and Myanmar rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
- Indonesia ranks 40th and Myanmar ranks 43rd of 56 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.